Graves’ Ophthalmopathy (Thyroid Eye Disease)
Understanding Thyroid Eye Disease
Graves’ ophthalmopathy, which is also known as thyroid eye disease or TED, is an eye disorder that can accompany hyperthyroidism in patients with Graves’ disease. Using sophisticated imaging techniques, such as magnetic resonance imaging (MRI), eye changes attributed to Graves’ ophthalmopathy such as swelling are seen in nearly 80 percent of patients with Graves’ disease.
Incidence of Clinically Significant Disease
Clinically significant eye changes requiring treatment intervention are seen in about 30 percent of patients with Graves’ disease. Overall, 80 percent of all clinically significant TED is seen in patients with Graves’ disease. Another 10 percent of cases are seen in patients with Hashimoto’s thyroiditis and the remaining 10 percent of cases are seen in patients with no evidence of thyroid dysfunction (euthyroid Graves’ disease).
Symptoms
Many different symptoms of TED can occur although most patients develop several predominant symptoms. Common symptoms include:
- Exophthalmos (proptosis or bulging)
- Dryness Redness (erythema)
- Eyelid lag
- Eyelid retraction
- Blurred vision
- Tearing
- Grittiness
- Foreign body sensation
- Double vision (diplopia)
- Staring appearance
Subtypes of TED
Symptoms of TED can occur as a result of abnormal thyroid hormone levels or as an autoimmune process, which runs its own course independent of the thyroid condition. Most conditions of TED are caused when levels of thyroid hormone are too high (hyperthyroidism). These eye conditions resolve spontaneously shortly after thyroid hormone levels return to the normal range.
Autoimmune TED is thought to be caused by a combination of genetic and environmental factors. TSH receptor antibodies and immune system chemicals known as cytokines both contribute to the autoimmune mechanism in TED. Environmental triggers include cigarette smoke, low selenium levels and stress.
Continued...